Indications of 5-Aminolevulinic Acid and Intraoperative MRI in Glioma Surgery: First Cases in Latin America in a Single Reference Center

 

 Permissions and Reprints

Abstract

Introduction The improvement on the extent of resection (EOR) of gliomas with the combination of 5-aminolevulinic acid (5-ALA) and intraoperative magnetic resonance imaging (iMRI) has been demonstrated in previous studies. We present our results with the combined use of 5-ALA and (iMRI) in the surgery of glial lesions.

Methods A total of 64 cases of patients with intracranial gliomas who underwent image-guided surgery using 5-ALA with and without (iMRI) were reviewed. All patients underwent an early postoperative MRI to evaluate the EOR. Other intra-operative techniques (awake surgery, electrophysiological stimulation and monitoring) were also performed according to the location of the tumor.

Results A total of 18 tumors did not show intraoperative 5-ALA fluorescence (according to the World Health Organization [WHO] classification of tumors, 2 WHO-grade I, 14 WHO-grade II, 1 WHO-grade III and 1 WHO-grade IV), and 46 tumors showed intraoperative 5-ALA fluorescence (3 WHO-grade II, 3 WHO-grade III, 40 WHO-grade IV). In 28 of the 46 5-ALA positive cases, a safe 5-ALA free resection was achieved. In the 5-ALA negative cases, the (iMRI) findings guided the EOR, and complete resection was achieved in 11 cases. Complete resection was opted out in gliomas infiltrating eloquent areas.

Conclusions The combined use of 5-ALA and IMRI showed improved results in glioma surgery, offering the safest maximal EOR. In the 5-ALA positive cases (mostly high-grade), fluorescence was a more useful tool. In the 5- ALA negative cases (mostly low-grade), the (iMRI) was decisive to guide the EOR of the tumor.

Resumo

Introdução Em estudos anteriores, foi demonstrado um aperfeiçoamento na extensão da resecção (EDR) de gliomas com a combinação de ácido 5-aminolevulínico (5-ALA) e a imagem de ressonância magnética intraoperatória (iRM). Nossos resultados são apresentados com o uso combinado de 5-ALA e (iRM) para a cirurgia de lesões gliais.

Métodos Foram revisados 64 casos de gliomas intracranianos submetidos a cirurgia guiada por imagem por meio do uso de 5-ALA, com ou sem RMI. Todos os pacientes foram submetidos a ressonância magnética (RM) pré-operatória para a avaliação da EDR do tumor. Outras técnicas intraoperatórias (cirurgia acordado, estimulação eletrofisiológica e monitoração) também foram realizadas segundo a localização do tumor.

Resultados Um total de 18 tumores não apresentaram fluorescência com o 5-ALA (segundo a classificação de tumores da Organização Mundial de Saúde [OMS], 2 com grau OMS I, 14 com grau II, 1 com grau III e 1 com grau IV) e 46 tumores foram fluorescentes (3 com grau II, 3 com grau III, 40 com grau IV). Dos 46 casos positivos para 5-ALA, em 28 foi obtida uma ressecção segura e livre. Nos casos negativos para 5-ALA, os achados da (iRM) orientaram a EDR, e alcançou-se ressecção total em 11 casos. A ressecção total foi descartada em gliomas com infiltração em áreas eloquentes.

Conclusões O uso combinado de 5-ALA e (iRM) mostrou melhores resultados na cirurgia de gliomas, oferecendo uma EDR de segurança máxima. Nos casos positivos para 5-ALA (a maioria de grau alto), a fluorescência mostrou-se um instrumento mais útil. Nos casos negativos para 5-ALA (a maioria de grau baixo), a RMI foi decisiva para orientar a EDR tumoral.

• References

• 1 Lacroix M, Abi-Said D, Fourney DR. , et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95 (02) 190-198 . Doi: 10.3171/jns.2001.95.2.0190
  CrossrefPubMedGoogle Scholar
• 2 Bloch O, Han SJ, Cha S. , et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 2012; 117 (06) 1032-1038 . Doi: 10.3171/2012.9.JNS12504
  CrossrefPubMedGoogle Scholar
• 3 Eseonu CI, ReFaey K, Garcia O, Raghuraman G, Quinones-Hinojosa A. Volumetric analysis of extent of resection, survival, and surgical outcomes for insular gliomas. World Neurosurg 2017; 103: 265-274 . Doi: 10.1016/j.wneu.2017.04.002
  CrossrefPubMedGoogle Scholar
• 4 Barone DG, Lawrie TA, Hart MG. Image guided surgery for the resection of brain tumours. Cochrane Database Syst Rev 2014; (01) CD009685 . Doi: 10.1002/14651858.CD009685.pub2
  PubMedGoogle Scholar
• 5 Tsugu A, Ishizaka H, Mizokami Y. , et al. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosurg 2011; 76 (1-2): 120-127 . Doi: 10.1016/j.wneu.2011.02.005
  CrossrefPubMedGoogle Scholar
• 6 Gessler F, Forster MT, Duetzmann S. , et al. Combination of Intraoperative Magnetic Resonance Imaging and Intraoperative Fluorescence to Enhance the Resection of Contrast Enhancing Gliomas. Neurosurgery 2015; 77 (01) 16-22 , discussion 22. Doi: 10.1227/NEU.0000000000000729
  CrossrefPubMedGoogle Scholar
• 7 Hauser SB, Kockro RA, Actor B, Sarnthein J, Bernays RL. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Neurosurgery 2016; 78 (04) 475-483 . Doi: 10.1227/NEU.0000000000001035
  CrossrefPubMedGoogle Scholar
• 8 Quick-Weller J, Lescher S, Forster MT, Konczalla J, Seifert V, Senft C. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma. Br J Neurosurg 2016; 30 (03) 313-317 . Doi: 10.3109/02688697.2015.1119242
  CrossrefPubMedGoogle Scholar
• 9 Schatlo B, Fandino J, Smoll NR. , et al. Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery. Neuro-oncol 2015; 17 (12) 1560-1567 . Doi: 10.1093/neuonc/nov049
  PubMedGoogle Scholar
• 10 Stummer W, Stepp H, Wiestler OD, Pichlmeier U. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas. Neurosurgery 2017; 81 (02) 230-239 . Doi: 10.1093/neuros/nyx074
  CrossrefPubMedGoogle Scholar
• 11 Chaichana KL, Jusue-Torres I, Navarro-Ramirez R. , et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro-oncol 2014; 16 (01) 113-122 . Doi: 10.1093/neuonc/not137
  PubMedGoogle Scholar
• 12 McGirt MJ, Chaichana KL, Gathinji M. , et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 2009; 110 (01) 156-162 . Doi: 10.3171/2008.4.17536
  CrossrefPubMedGoogle Scholar
• 13 Brown TJ, Brennan MC, Li M. , et al. Association of the extent of resection with survival in glioblastoma: A systematic review and meta-analysis. JAMA Oncol 2016; 2 (11) 1460-1469 . Doi: 10.1001/jamaoncol.2016.1373
  CrossrefPubMedGoogle Scholar
• 14 Alexander III E, Moriarty TM, Kikinis R, Jolesz FA. Innovations in minimalism: intraoperative MRI. Clin Neurosurg 1996; 43: 338-352
  PubMedGoogle Scholar
• 15 Black PM, Moriarty T, Alexander III E. , et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 1997; 41 (04) 831-842 , discussion 842–845. Doi: 10.1097/00006123-199710000-00013
  CrossrefPubMedGoogle Scholar
• 16 Nimsky C, Ganslandt O, Kober H, Buchfelder M, Fahlbusch R. Intraoperative magnetic resonance imaging combined with neuronavigation: a new concept. Neurosurgery 2001; 48 (05) 1082-1089 , discussion 1089–1091. Doi: 10.1097/00006123-200105000-0002
  PubMedGoogle Scholar
• 17 Reyns N, Leroy HA, Delmaire C, Derre B, Le-Rhun E, Lejeune JP. Intraoperative MRI for the management of brain lesions adjacent to eloquent areas. Neurochirurgie 2017; 63 (03) 181-188 . Doi: 10.1016/j.neuchi.2016.12.006
  CrossrefPubMedGoogle Scholar
• 18 Ramina R, Coelho Neto M, Giacomelli A. , et al. Optimizing costs of intraoperative magnetic resonance imaging. A series of 29 glioma cases. Acta Neurochir (Wien) 2010; 152 (01) 27-33 . Doi: 10.1007/s00701-009-0430-2
  CrossrefPubMedGoogle Scholar
• 19 Stummer W, Stepp H, Möller G, Ehrhardt A, Leonhard M, Reulen HJ. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) 1998; 140 (10) 995-1000
  CrossrefPubMedGoogle Scholar
• 20 Stummer W, Stocker S, Wagner S. , et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998; 42 (03) 518-525 , discussion 525–526
  CrossrefPubMedGoogle Scholar
• 21 Senders JT, Muskens IS, Schnoor R. , et al. Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results. Acta Neurochir (Wien) 2017; 159 (01) 151-167 . Doi: 10.1007/s00701-016-3028-5
  CrossrefPubMedGoogle Scholar
• 22 Stummer W, Tonn JC, Mehdorn HM. , et al; ALA-Glioma Study Group. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. J Neurosurg 2011; 114 (03) 613-623 . Doi: 10.3171/2010.3.JNS097
  CrossrefPubMedGoogle Scholar
• 23 Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. ; ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006; 7 (05) 392-401
  CrossrefPubMedGoogle Scholar
• 24 Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 2011; 12 (11) 997-1003 . Doi: 10.1016/S1470-2045(11)70196-6
  CrossrefPubMedGoogle Scholar
• 25 Eyüpoglu IY, Hore N, Savaskan NE. , et al. Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PLoS One 2012; 7 (09) e44885 . Doi: 10.1371/journal.pone.0044885
  CrossrefPubMedGoogle Scholar
• 26 Coburger J, Engelke J, Scheuerle A. , et al. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment. Neurosurg Focus 2014; 36 (02) E3 . Doi: 10.3171/2013.11.FOCUS13463
  PubMedGoogle Scholar
• 27 Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93 (06) 1003-1013 . Doi: 10.3171/jns.2000.93.6.1003
  CrossrefPubMedGoogle Scholar
• 28 Panciani PP, Fontanella M, Schatlo B. , et al. Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg 2012; 114 (01) 37-41 . Doi: 10.1016/j.clineuro.2011.09.001
  CrossrefPubMedGoogle Scholar
• 29 Díez Valle R, Tejada Solis S, Idoate Gastearena MA, García de Eulate R, Domínguez Echávarri P, Aristu Mendiroz J. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 2011; 102 (01) 105-113 . Doi: 10.1007/s11060-010-0296-4
  CrossrefPubMedGoogle Scholar
• 30 Roberts DW, Valdés PA, Harris BT. , et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 2011; 114 (03) 595-603 . Doi: 10.3171/2010.2.JNS091322
  CrossrefPubMedGoogle Scholar